Citi downgraded QuidelOrtho (QDEL) to Neutral from Buy with a price target of $33, down from $40. The firm cites a lack of upside to the company’s mid-single-digit growth outlook for the downgrade. Citi sees challenges with the LEX launch and higher interest expense pressuring QuidelOrtho’s fiscal 2025 earnings.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QDEL: